Reporting
Latest stories
Markets, companies and the economy, with the date and primary source attached.
Option Care Health jumps after report McKesson and CD&R are near a $5 billion-plus buyout
Shares of the largest independent U.S. home-infusion provider rose about 21% after the close. No deal has been announced, and the talks could still fall apart.
GE HealthCare agrees to buy radioactive-drug maker Sofie Biosciences for $945 million in cash
The deal gives GE HealthCare its own U.S. network for producing PET imaging drugs that decay within hours, plus U.S. rights to an experimental cancer tracer. It is expected to close in the first half of 2027.
Washington's crypto agencies write the rules Congress wouldn't: FinCEN kills the wallet and mixer proposals as the CFTC moves
FinCEN withdrew two dormant crypto crackdowns; the CFTC proposed leveraged-crypto registration rules; Canary's Litecoin ETF hit record reserves as the SEC's queue churns — and OKX's ICE venture filed for 24/7 tokenized stocks.
Genmab and AbbVie say adding their lymphoma drug to standard chemotherapy halved the risk of progression or death in a late-stage trial
Topline results from a Phase 3 trial put epcoritamab in line for a role in first-line treatment of the most common lymphoma. Full data are not out yet, and the combination is not approved.
Vistra gets a conditional U.S. loan offer of up to $4.2 billion to boost output at three nuclear plants
The Energy Department's conditional offer would help pay for upgrades adding 433 megawatts at Beaver Valley, Davis-Besse and Perry. Vistra must still meet the department's conditions before any money is lent.
Prices paid by U.S. service businesses hit their highest since 2022 as the ISM index eases to 54.9
Fuel costs dominated September's survey. The headline index slipped to 54.9 and hiring turned up, leaving the Fed with a services sector that is still growing while its costs climb.
Brazil's stock index tops 200,000 for the first time and the dollar breaks below R$5 after Flávio Bolsonaro's first-round lead
The Ibovespa was up more than 8% in the afternoon, on pace for its best day since March 2020, and long-dated rate futures fell more than a full percentage point. The Oct. 25 runoff will decide whether the move lasts.
C.H. Robinson agrees to buy RXO for $5.8 billion, but its stock slide cuts the offer below $30.25
RXO holders would get $17.25 in cash and 0.0856 of a C.H. Robinson share each. With the buyer's stock down 14% at midday, that was worth about $28.86. An RXO vote and antitrust clearance are still needed.
Cenovus agrees to buy Athabasca Oil in C$5.7 billion oil sands deal
Athabasca holders can take C$12 a share in cash, 0.264 of a Cenovus share or a mix, with cash capped at 75% of the total. The deal needs a shareholder vote and Competition Act clearance before a planned December close.
Vaxcyte surges as its 31-strain pneumococcal vaccine meets main goals in pivotal trial
VAX-31 met every primary goal in a 4,047-person study against Pfizer's Prevnar 20 and Merck's Capvaxive, though two strains fell short of a stricter bar against Merck's shot. A U.S. filing is planned for the first half of 2028.
Intel slides as Musk confirms early TSMC talks on his Texas Terafab chip project
Intel has been the only publicly named chipmaking partner in Musk's Terafab, and Tesla has said it will use Intel's 14A process there. Musk called the TSMC talks "just discussions," and no deal or terms have been disclosed.
Euro hits 17-month low as French bond stress builds and Spain calls snap election
France's borrowing premium over Germany touched its widest since 2011 last week as doubts grew about its 2027 budget. Spain's Pedro Sánchez then set a Nov. 29 election, and ECB officials say they are not targeting spreads.
Qualcomm agrees to license and buy Huawei patents in 5G and AI deal
The multiyear cross-license covers 5G, computing, AI and networking. Qualcomm's purchase of some Huawei U.S. patents still needs regulatory approval, and neither company disclosed what money changes hands.
Shionogi agrees to buy IntraBio for $2 billion, adding rare-disease drug Aqneursa
The Japanese drugmaker's U.S. unit will pay $2 billion upfront for all of IntraBio's shares. It is a signed agreement, not a completed deal: closing is planned for November or December, after competition and regulatory reviews.
Schneider Electric agrees to buy PTC for $205 a share in $22.6 billion cash deal
The all-cash price is 42.3% above PTC's Friday close, for an enterprise value of $23.7 billion. It is an agreement, not a done deal: closing is expected by the third quarter of 2027, pending a PTC vote and regulators.
Yemen opens offensive on Houthis, who claim Aramco strikes; oil's early jump fades
The Saudi-backed government said Sunday it is pushing to retake all Houthi-held land. The Houthis claimed same-day strikes on Aramco that Riyadh has not confirmed. Brent topped $103 early in Asia trading, then slipped below Friday's close.
Brazil ETF jumps in Tokyo after Flávio Bolsonaro edges Lula in first round
Flávio Bolsonaro finished ahead of President Lula in Sunday's first round, about 47.4% to 44.7% of valid votes, setting up an October 25 runoff; a Japan-listed Brazil stock ETF rose 7.6% in early Monday trading.
Suncor agrees to sell offshore stakes to Ithaca, lifts buyback to C$750M a month
Suncor agreed to sell its Terra Nova, White Rose and West White Rose stakes to Ithaca Energy for C$1.2 billion upfront, with up to C$350 million more tied to oil prices, and raised its monthly buyback to C$750 million.
Micron's AI memory boom is increasingly contracted years in advance
Twenty-six take-or-pay customer agreements now underpin about $150 billion in remaining performance obligations — and the vast majority of 2027's HBM supply is already committed at much higher prices.
Paramount’s $52 billion Warner financing faces an early bond-market test
The debt syndication is complete, Bloomberg reports, but weak initial trading puts the cost of financing in focus ahead of the companies’ expected October 6 merger.
ICBA sues OCC over crypto trust-bank charter rules
The community banking group challenges the regulator's legal authority and Protego's conditional approval. The OCC has described the disputed rule as a clarification of existing powers.
G7 agrees oil-stock release of up to 100 million barrels, with diesel first
The four-month plan calls for a substantial diesel release in the first 20 days, while leaders pledge to keep energy trade open within the group.
DOJ says it will not reopen Powell probe as Fed renovation oversight continues
A department spokesperson confirmed the position to Reuters. The Fed watchdog found no grounds for a criminal referral, while identifying management failures and recommending corrective action.
Broadcom assembling $60 billion debt syndicate to fund Anthropic chips, Bloomberg reports
A reported $60 billion debt package to fund AI chips for Anthropic: a $42 billion senior tranche banks are poised to syndicate, plus an $18 billion junior slice led by Blackstone, per Bloomberg.
Raytheon wins SM-6 contract worth up to $24.4 billion as production expands
The award runs for five years, with two additional option years. RTX's earlier expansion plan targets more than 500 missiles annually, but the contract ceiling is not an annual revenue forecast.